Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 15Unknown 3Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 15INDUSTRY 3OTHER_GOV 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Classical hematology 3

Conditions

Neoplasms 183Breast Neoplasms 174Carcinoma, Non-Small-Cell Lung 173Colorectal Neoplasms 105Stomach Neoplasms 81Pancreatic Neoplasms 79Lung Neoplasms 79Prostatic Neoplasms 77Melanoma 68Neoplasm Metastasis 67Recurrence 66Leukemia, Myeloid, Acute 66Multiple Myeloma 64Ovarian Neoplasms 62Carcinoma, Hepatocellular 62Lymphoma 61Advanced Solid Tumor 61Advanced Solid Tumors 56Solid Tumor 50Uterine Cervical Neoplasms 48Lymphoma, Non-Hodgkin 48Glioblastoma 44Lymphoma, B-Cell 40Leukemia 39Colonic Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Head and Neck Neoplasms 33Esophageal Neoplasms 32Urinary Bladder Neoplasms 30Sarcoma 30

Interventions

pegfilgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Febrile Neutropenia × Clear all
NCT04662892 2020-12-23

POEM

Coherus Oncology, Inc.

Unknown
200 enrolled
Classical hematology

Febrile Neutropenia

NCT02544685 2019-01-17

FENSY

S&D Pharma SK s.r.o.

Phase 2 Unknown
120 enrolled
Classical hematology

Neoplasms, Neutropenia, Febrile Neutropenia

NCT01560195 2012-11-06

A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Unknown
150 enrolled
Classical hematology

Neutropenia, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡